If you have an autoimmune disorder, your doctor undoubtedly recommended regular mild workouts to help…
Subscribe to Updates
Get health & wellness insight updates.
Quick Hits: FDA Approves New Drugs for Multiple Sclerosis, Eczema and Warning About Heart Drug
The FDA approved Ocrevus (ocrelizumab) as the first-ever drug to treat primary progressive multiple sclerosis (PPMS), a serious form of…
More Digoxin Cautions: Use in AF, Heart Failure Raises Mortality in Meta-analysis
Researchers from Goethe University, Frankfurt, Germany reported that digoxin use was linked with a 29% increased risk of mortality in…
Patients who take the heart rhythm drug digoxin may face a nearly 30% greater risk of death than patients not…
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
Symptoms & Concerns
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward